Reboxetine
EDRONAX
What it isSelective norepinephrine reuptake inhibitor; depression outside the US.
Why this onePurely noradrenergic, so sexual dysfunction is uncommon.
What limits itEfficacy was disputed after unpublished trials were released, and it was never US-approved. Insomnia, dry mouth and urinary hesitancy.
NO BOXED WARNINGS
Principal riskDisputed efficacy; never US-approved
Classes and tags
Clinical profile
Mechanism of action: Reboxetine ballicule
